Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
RARE US​

Ultragenyx Pharmaceutical Inc.(RARE US)

$15.65-0.301.88%Ext:$15.41-0.241.56%(Market Closed · 23:56:08 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income StatementBalance Sheet

Cash Flow

Millions USD (ex. Per Share)
FY201112/31/2011
FY201212/31/2012
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-606.6-569.2-575.0-608.9
Depreciation & Amortization26.035.535.013.6
Stock Based Compensation135.2158.0153.0142.8
Change in Working Capital-15.113.9-23.0-17.4
Other Non-Cash Items-12.7-52.5-56.0-26.7
Net Cash from Operating Activities-474.8-414.2-466.0-496.5
-Investments in Property, Plant & Equipment-44.3-7.5-6.0-5.7
-Acquisitions Net----
-Purchases of Investments-526.4-408.6-186.0-317.0
Sales/Maturities of Investments746.2413.3444.0395.0
Other Investing Activities-7.5-14.9-16.0-5.2
Net Cash from Investing Activities168.0-17.8236.067.1
Net Debt Issuance--392.0392.0
Net Stock Issuance379.8381.086.085.8
-Net Dividends Paid----
Other Financing Activities8.418.3--
Net Cash from Financing Activities388.1399.2478.0477.8
Effect of Forex Changes0.5-2.55.5-2.2
Net Change in Cash81.8-35.2253.546.2
Cash at End of Period219.4184.2436.01,022.3
Operating Cash Flow-474.8-414.2-466.0-496.5
-Capital Expenditure-46.8-7.5-6.09.3
Free Cash Flow-521.6-421.7-472.0-487.2